|June 17, 2014|
|16:27 EDT||CBI, MCRS, ACOR, SCTY, GWPH, ORCL||On The Fly: Closing Wrap|
Stocks on Wall Street began the day in negative territory, thanks in part to worse than expected economic data. The consumer price index came in higher than expected, while housing starts and building permits both came in well below analysts' consensus forecasts. The averages drifted off their opening lows and eventually made it into positive territory, where the market drifted for most of the rest of the day. The volume was light, as investors sat on the sidelines while the Federal Reserve board convened for the central bank's latest rate setting and policy meeting. ECONOMIC EVENTS: In the U.S., the consumer price index rose 0.4% in May, which was above the consensus forecast for an increase of 0.2%. Housing starts in the month declined 6.5% to a rate of about 1M and building permits slid 6.4% to a rate of 991K, which were both lower than expected. The Federal Reserve began its latest Federal Open Market Committee meeting, which will conclude tomorrow. COMPANY NEWS: Elon Musk's SolarCity (SCTY) advanced $9.65, or 17.58%, to $64.53 after the solar energy system installer agreed to acquire solar panel technology and manufacturing company Silevo for up to $350M dollars. SolarCity said it sees its manufacturing capacity allowing it to create "the most vertically integrated solar company" with an "industry-leading" cost structure that aims to make solar competitive with grid costs. The company also said it is in talks with the state of New York to build a plant with targeted capacity greater than 1 GW within the next two years, which it says will be "one of the single largest solar panel production plants in the world." MAJOR MOVERS: Among the notable gainers was register system and hospitality software maker Micros Systems (MCRS), which surged $8.62, or 14.94%, to $66.33 after Bloomberg reported that the company is in talks to be acquired by tech giant Oracle (ORCL) for "more than" $5B. Also higher was GW Pharmaceuticals (GWPH), which jumped $12.57, or 16.27%, to $89.82 after it announced physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with GW's investigational cannabidiol product candidate, Epidiolex, for a period of 12 weeks. Among the noteworthy losers was Chicago Bridge & Iron (CBI), which fell $5.32, or 7.23%, to $68.26 after research firm Prescience Point alleged that the company has used "creative acquisition accounting" to conceal its losses and placed a Strong Sell rating on the shares. Also lower were shares of Acorda Therapeutics (ACOR), which fell $3.16, or 8.96%, to $32.12 after announcing an offering of $300M of convertible senior notes. INDEXES: The Dow was up 27.48, or 0.16%, to 16,808.49, the Nasdaq was up 16.13, or 0.37%, to 4,337.23, and the S&P 500 was up 4.21, or 0.22%, to 1,941.99.
News For MCRS;ORCL;SCTY;CBI;GWPH;ACOR From The Last 14 Days
|October 1, 2015|
|09:10 EDT||SCTY||SolarCity selloff overdone, remains a top pick at Goldman|
Goldman said the selloff in SolarCity shares is overdone and remains a top pick across solar coverage. Analyst Brian Lee believes shares are poised to benefit from second half catalysts that include the November analyst day, incremental data around financing, and continued execution. Lee reiterates his Conviction Buy rating and $79 price target on shares.
|September 30, 2015|
|08:01 EDT||CBI||CB&I awarded $100M federal fuel services contract|
CB&I announced it has been awarded a contract valued at approximately $100M by the U.S. Federal Government to provide fuel services at military installations around the world.
|06:58 EDT||ORCL||Oracle to furlough workers during holiday week, BI reports|
Oracle has decided to close down during the holiday week between Christmas and New Year's, mandating that its employees pay for this furlough with paid vacation time, Business Insider reports, citing several sources. Some Oracle employees have been angered about this move that basically removes four days of paid time off from them, the report says. Reference Link
|September 29, 2015|
|08:39 EDT||ORCL||Oracle Health Sciences adds 93 biopharma customers|
Oracle (ORCL) Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster. Organizations, including Accera and NewLink (NLNK), selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.
|September 24, 2015|
|10:01 EDT||SCTY||On The Fly: Analyst Initiation Summary|
Subscribe for More Information
|06:14 EDT||SCTY||SolarCity initiated with a Buy at Stifel|
|September 23, 2015|
|16:07 EDT||CBI||Chicago Bridge & Iron awarded contract for ethylene cracker project|
Subscribe for More Information
|10:20 EDT||ORCL||Options with decreasing implied volatility|
Options with decreasing implied volatility: CVC HRTX NWBO ATML RHT KMX OVTI ADBE ORCL DRI
|September 22, 2015|
|10:14 EDT||SCTY||Options with decreasing implied volatility|
Options with decreasing implied volatility: CVC ADXS SRPT ATML YY SCTY OLN ADBE RHT ASNA
|September 21, 2015|
|10:22 EDT||SCTY||Options with decreasing implied volatility|
Options with decreasing implied volatility: ADXS CVC NWBO RPTP ATML QIHU ARIA LNG MBLY SCTY